Lv52
1220 积分 2024-11-12 加入
PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial
6天前
已完结
Predictors of durable HBsAg loss after pegylated interferon-based therapy in HBeAg-negative CHB patients: a multicenter real-world study
6天前
已完结
Impact of age at HBsAg seroclearance on hepatic outcomes and life expectancy in men with chronic HBV infection based on multi-state modeling of the natural history
16天前
已完结
FRI-397 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
1个月前
已完结
Impact of age at HBsAg seroclearance on hepatic outcomes and life expectancy in men with chronic HBV infection based on multi-state modeling of the natural history
1个月前
已完结
Liver Elastography-based Risk Score for Predicting Hepatocellular Carcinoma Risk
2个月前
已完结
DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL FOR INDIVIDUAL CANCER RISK ASSESSMENT FOR THYROID NODULES
2个月前
已完结
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B
2个月前
已完结
Interpretable machine learning model for prediction functional cure in chronic hepatitis B patients receiving Peg-IFN therapy: A multi-center study
2个月前
已完结
Estimating and comparing time‐dependent areas under receiver operating characteristic curves for censored event times with competing risks
2个月前
已完结
皖公网安备34019202002308
